Dagmura, H. Et Al. 2021. The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS .

Dagmura, H., DALDAL, E., & OKAN, İ., (2021). The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS .

Dagmura, Hasan, EMİN DALDAL, And İSMAİL OKAN. "The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2021

Dagmura, Hasan Et Al. "The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2021

Dagmura, H. DALDAL, E. And OKAN, İ. (2021) . "The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS .

@article{article, author={Hasan Dagmura Et Al. }, title={The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery}, journal={CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS}, year=2021}